RNA Outsourcing Resources
-
Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer
12/5/2024
This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.
-
Transforming Patient Access To CGT
4/28/2025
Chief Commercial Officer Aruna Mor recently delivered a powerful keynote at the Advanced Therapies Congress in London, highlighting the challenges of patient access to advanced therapies.
-
The Critical Bottleneck In Personalized Cancer Vaccines
6/19/2026
Personalized cancer vaccines face a DNA production bottleneck. Synthetic approaches speed timelines, boost consistency, and simplify workflows to deliver individualized therapies faster.
-
The Switch To Cell-Free DNA: Strategic And Regulatory Considerations
4/24/2026
Learn how risk-based studies, quality attributes, and proactive regulatory engagement support confident manufacturing transitions.
-
mRNA: How To Build A Custom Program Using CDMO Services
1/4/2023
Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.
-
Eliminating Antibiotic Resistance Gene Transfer Risks In CGTs
8/14/2023
Learn about the drawbacks of antibiotic resistance that can cause side effects in patients and how an antibiotic-free approach can ease the burden of regulatory compliance and accelerate development.
-
All You Need To Know About GMP Manufacturing Of mRNA-LNP Drug Products
10/13/2026
Moving mRNA-LNP production from lab to GMP scale exposes tensions among formulation consistency, regulatory expectations, and facility safety, while automation offers ways to resolve them.
-
Enhancing Safety And Efficacy Of mRNA-Based Therapeutics
2/11/2025
Discover how Codex® HiCap RNA Polymerase optimizes mRNA yield while reducing dsRNA byproducts for safer, more effective therapeutics.
-
Delivering The Promise Of Gene Therapy
1/22/2024
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
Supporting Compliance And Reducing Risk In Gene Therapy Logistics
2/4/2025
Ensure the safe, compliant, and seamless delivery of gene therapies by leveraging advanced logistics solutions designed to meet stringent regulatory standards and mitigate risk at every stage.